We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Read our policy.

Stay at the forefront of the industrial gas industry with a gasworld subscription and get access to:

Stay at the forefront of the industrial gas industry with a gasworld subscription and get access to:

Issue 207 July 2022 - Gas Analysis & Control

Gasworld US Edition, Vol 60, No 08 (August) - Helium

By Nick Parkinson 2020-06-03T16:14:00+01:00

CAIRE Inc. has acquired Spirosure, Inc. to expand CAIRE’s portfolio into the diagnostic segment of respiratory care.

Spirosure Fenom Pro Asthma testing

Spirosure is a California-based developer and manufacturer of an innovative technology for measuring fractional exhaled nitric oxide, which is a key indicator of allergic inflammation in asthmatic patients. 

Spirosure will operate as a division of Georgia, US-based CAIRE to be known as CAIRE Diagnostics Inc.

Japan-based NGK Spark Plug Co., Ltd. acquired CAIRE in December 2018 to establish a global foothold in the respiratory therapy business and had previously invested in Spirosure as the latter company’s technology was in development.

“We are very pleased to have found an excellent strategic buyer in CAIRE through one of our key investors,” said Solomon Ssenyange, PhD, CEO and Chairman of Spirosure.

“CAIRE shares our commitment to technological leadership and, with its large international organisation, is well-positioned to realise the full potential of our proprietary technology both commercially and with regard to our development pipeline. We look forward to an exciting future as part of CAIRE.”

Spirosure recently launched its first product to market, the Fenom Pro®, a reliable and convenient to use device that accurately measures fractional exhaled nitric oxide at parts-per-billion levels using a proprietary sensor technology. The product is intended to be used in the clinic setting and is currently available in the US, the EU and India.

CAIRE, a global manufacturer of oxygen supply equipment, has a portfolio marketed under the AirSep®, CAIRE®, HELiOS™ and SeQual® brands, which includes portable and stationary oxygen therapy devices and turnkey on-site generation commercial solutions.

CAIRE is celebrating a major achievement, having confirmed that its FreeStyle® Comfort® portable oxygen concentrator has outperformed other similar devices in a recent study designed to assess the effectiveness of delivering oxygen to patients.

AirSep Corporation, a division of CAIRE Inc., has confirmed two AirSep ASV97000 VPSA Oxygen Systems are part of upgrading one of the largest sewage treatment plants in the Southeastern US.

gas world has in the last few days launched a brand new content and information platform dedicated to the fast-growing Asia-Pacific industrial gases business.

Month on month, the gasworld website is the market-leading news portal for the global industrial gas sector, growing at an unprecedented rate and keeping its readers at the forefront of breaking news, insightful analysis and must-see features across the industry. Launched in 2003 and continually evolving, it is the only independent online news, views and intelligence portal for the global industrial gas community and the larger end-user markets – and home to the ever-increasing range of gasworld platforms.

To find out more about gasworld's advertising opportunities click here.

Whether it's web-based or the printed product, gasworld subscriptions have the value-added solutions for you.

Find out more... gasworld Magazine gasworld (US edition) Subscribe today

Site powered by Webvision Cloud